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Abstract
Background: Heterozygous and homozygous carriers of SCN5A-p.Ser1103Tyr, a common genetic variant with 
functional effects among African-Americans, have an increased risk of sudden death. We hypothesized that some 
heterozygous carriers may have unequal expression of wild-type and variant alleles and secondarily that 
predominance of the variant gene copy could further increase risk for sudden death in this population.
Methods: We quantified allele-specific expression of SCN5A-p.Ser1103Tyr by real-time reverse-transcription 
polymerase chain reaction (RT-PCR) in heart tissue from heterozygous African-American infants, who died from sudden 
infant death syndrome (SIDS) or from other causes, to test for allelic expression imbalance.
Results: We observed significant allelic expression imbalance in 13 of 26 (50%) African-American infant hearts 
heterozygous for SCN5A-p.Ser1103Tyr, and a significant (p < 0.0001) bimodal distribution of log2 allelic expression 
ratios. However, there were no significant differences in the mean log2 allelic expression ratios in hearts of infants dying 
from SIDS as compared to infants dying from other causes and no significant difference in the proportion of cases with 
greater expression of the variant allele.
Conclusions: Our data provide evidence that SCN5A allelic expression imbalance occurs in African-Americans 
heterozygous for p.Ser1103Tyr, but this phenomenon alone does not appear to be a marker for risk of SIDS.
Background
Every year in the United States more than 300,000 people
die suddenly from an unexpected cardiac event [1], with
coronary artery disease accounting for 80% of sudden
cardiac death (SCD) in the adult population [2]. However,
in children and adolescents, inherited arrhythmias, such
as long-QT syndrome, Brugada syndrome, familial atrial
fibrillation, catecholaminergic polymorphic ventricular
tachycardia, and Wolff-Parkinson-White syndrome, are a
leading cause of sudden death [2]. Sudden death from
cardiac causes is more common in African-Americans
than in Caucasians [3,4]. In adults, sudden death from
nonatherosclerotic heart disease is more frequent in Afri-
can-Americans, while during infancy, African-Americans
are twice as likely as Caucasians to die from sudden infant
death syndrome (SIDS) [5].
Mutations in SCN5A, the gene encoding the pore-
forming α-subunit of the cardiac voltage-gated sodium
channel, have been associated with sudden death in long
QT syndrome and Brugada syndrome [6]. A common
SCN5A genetic variant (p.Ser1103Tyr) that is found in
13% of African-Americans is associated with an increased
risk for cardiac arrhythmia and sudden cardiac death in
that population [7,8]. Further, the p.Ser1103Tyr variant is
over-represented in African-American SIDS victims as
compared to non-SIDS infant death cases [9,10] and
sodium channels with the variant allele exhibit functional
defects that may increase risk for life-threatening cardiac
arrhythmias [7]. Because infants dying suddenly and
unexpectedly are usually brought to autopsy, they provide
a unique opportunity for studying tissue-specific expres-
sion of a potentially lethal genetic variant.
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phenomenon [11,12]. We hypothesized that African-
Americans heterozygous for SCN5A-p.Ser1103Tyr
exhibit unequal expression of wild-type and variant
alleles (allelic expression imbalance) and that predomi-
nance of the variant gene copy might further increase the
risk for sudden death in this population.
Methods
Tissue samples
De-identified, frozen, postmortem heart tissues from
African-American SIDS cases and African-American
infant controls were obtained from two sources: the Ten-
nessee Medical Examiner (29 cases, 16 controls), and a
previously reported cohort collected at Mayo Clinic (10
cases, 30 controls) [10]. The SIDS cases from the Tennes-
see Medical Examiner met a rigorous definition of SIDS
[13] or sudden unexpected infant death (SUID) [14]. Use
of anonymous human tissues in this study was approved
by the Institutional Review Board of Vanderbilt Univer-
sity.
RNA extraction, cDNA synthesis, and genotyping
Total RNA was extracted from pulverized heart muscle
using TRIzol reagent (Invitrogen, Carlsbad, CA) accord-
ing to the reagent supplier's instructions, followed by
DNase digestion and final purification with RNeasy Min-
Elute (Qiagen, Valencia, CA). RNA quality was deter-
mined by spectrophotometry and gel electrophoresis,
and samples exhibiting degradation were not used. RNA
samples were diluted to a concentration of 1 μg/μl prior
to performing reverse transcription (RT) to synthesize
cDNA used for genotyping and for allele-specific mRNA
measurements. Reverse transcription was performed
using 3 μg RNA, 3.75 μM random hexamers (Applied
Biosystems, Foster City, CA), 0.5 mM deoxynucleoside
triphosphates (Roche, Basel, Switzerland), 1× M-MLV
buffer (Promega, Madison, WI), 10 mM DTT, 40 units
RNase inhibitor (Promega), and 200 units M-MLV
reverse transcriptase (Promega). Reverse-transcription
reactions were incubated sequentially for 10 minutes at
25°C, 50 minutes at 42°C, and 15 minutes at 70°C. Geno-
typing for the SCN5A-p.Ser1103Tyr (c.3308C>A) variant
was performed by direct sequencing of a 230 bp amplicon
(nucleotides 3217-3446 of the open reading frame of
Genbank: NM_198056) generated by RT-PCR (primers:
forward, TCCAGCAAGCAGCAGGAATC; reverse,
TCAGCGGTGTTGGTCATGTC) from each RNA sam-
ple. The SCN5A-p.Ser1103Tyr variant has also been des-
ignated as p.Ser1102Tyr based on the amino acid
sequence of an alternatively spliced transcript (Genbank:
NM_000335). To be consistent with the numbering
scheme used widely for SCN5A mutations, we used
p.Ser1103Tyr based upon the canonical transcript.
Allele-specific quantitative RT-PCR
Heterozygous samples were evaluated for SCN5A allelic
expression imbalance using real-time quantitative RT-
PCR and allele-specific TaqMan probes that contained a
minor groove binder (MGB) at the 3' end (p.Ser1103:
FAM-ACTGCCTCCTCTGA-MGB; p.Tyr1103: FAM-
ACTGCCTACTCTGA-MGB; allele-specific sequences
are underlined) to quantify the separate alleles. Amplifi-
cation primers (forward: CCCTCCGGATTCCAGGAC;
reverse: CTGCCCTCGGAGCAACTG) used in the assay
generated a 156 bp amplicon (nucleotides 3264-3419
based on the open reading frame of Genbank:
NM_198056) with a two-temperature cycling protocol
(95°C for 20 s followed by 45 cycles of 95°C, 1 s and 60°C,
20 s). Under these conditions neither TaqMan probe
exhibited cross-reactivity with the opposite allele. Ampli-
cons corresponding to each allele were cloned into a plas-
mid vector and used as cDNA standards. All reactions
were performed in triplicate on a 7900HT Fast Real-Time
PCR system (Applied Biosystems). Individual reactions
(20 μl) contained 1× Fast Universal PCR Master Mix
(Applied Biosystems), forward and reverse primers (3
μM), an allele-specific probe (10 μM), and 5 μl of cDNA
(or 5 μl water for template-negative controls). The ability
of the assay to quantitatively distinguish different propor-
tions of the two alleles with high specificity was assessed
using plasmid cDNA standards in the following mass
ratios (p.Tyr1103:p.Ser1103): 4:1, 2:1, 1:1, 1:2, and 1:4.
The cDNA standards were diluted to a final concentra-
tion of 0.001 ng/μl after preliminary studies determined
that this concentration produced cycle threshold values
similar to heart tissue RNA. Assays were performed in
triplicate and each RNA sample was assayed from 2-3
independent preparations of cDNA.
Data analysis
Initial data analysis was performed using Applied Biosys-
tems Sequence Detection System software (version 2.2.2).
Two principles guided our approach to deduce allelic
expression ratios. First, the cycle threshold (CT) is
inversely proportional to the copy number of the tem-
plate, assuming 100% amplification efficiency, and sec-
ond, there is a linear relationship between log2 of the
allele ratio and ΔCT (difference between CT values for
each allele). A standard curve generated from assaying
cDNA standards mixed at known ratios and fitted with
the equation log2(p.Tyr1103:p.Ser1103) = αΔCT + β (α
and β are fit parameters) was used to interpolate the ratio
of allele expression for case and control samples.
Statistical analysis was conducted using SAS (version
9.1.3, SAS institute, Cary, NC). Because multiple RT-PCR
allelic imbalance assays were performed for each case and
control, it was important to account for dependencies
from repeated observations from the same subject. To
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allele ratios, with log2(p.Tyr1103:p.Ser1103) as the out-
come variable, with fixed effects, including sample source
(Tennessee ME versus Mayo Clinic samples), age, gender,
group (cases vs. controls), and random effects, including
batch, subject and assay plate. The random batch effects
were created based on unique combinations of PCR date
and assay date. To obtain the estimates of Best Linear
Unbiased Prediction (BLUP) of allelic expression imbal-
ance for each subject, we constructed linear combina-
tions of estimated parameters from this mixed effect
model for each subject. Allelic imbalance was defined by
log2(p.Tyr1103:p.Ser1103) ratio significantly different
from zero. The null hypothesis,
log2(p.Tyr1103:p.Ser1103) = 0, describes the absence of
allelic imbalance. A Bonferroni-corrected p-value of p <
0.002 was considered statistically significant. We also
plotted the p.Tyr1103:p.Ser1103 log2 allelic expression
ratios for all cases and controls as a function of the count
and used the Gaussian Fit option in OriginPro7 (Origin-
Lab Corp., Northhampton, MA) to estimate the
smoothed density function of the mean log2 allelic
expression ratios. We then compared the goodness of fit
of a two component mixture model and a normal model
to the data using a likelihood ratio test.
Results
We identified 17 African-American SIDS cases and 9
African-American non-SIDS infant death controls that
were heterozygous for SCN5A-p.Ser1103Tyr and that had
available frozen heart tissue from which we were able to
isolate intact, high quality total RNA. We developed a
quantitative assay to measure allele-specific expression in
heart tissue from African-American infants heterozygous
for SCN5A-p.Ser1103Tyr using allele-specific real-time
reverse-transcription PCR (RT-PCR). Allelic imbalance
assays performed on monoallelic samples demonstrated
negligible allele cross-reactivity.
Analysis of all subjects revealed that 13 of 26 (50%)
African-American heterozygous infant hearts exhibited
log2 allelic expression ratios significantly different from
zero (p < 0.002), indicating the presence of allelic expres-
sion imbalance. Further, we observed a significant (p <
0.0001) bimodal distribution of log2 allelic expression
ratios (Fig. 1A). These data indicate that a subset of Afri-
can-American infants who are heterozygous for
p.Ser1103Tyr have unequal cardiac expression of the
common and variant alleles. In individuals subjects,
allelic expression imbalance was present in 10 of 17 cases
(59%) and 3 of 9 controls (33%; Fig. 1B). However, analysis
of allelic expression data using a mixed effects model
demonstrated that the log2 p.Tyr1103:p.Ser1103 expres-
sion ratios for SIDS cases was not significantly different
from that of the controls. Further, the proportion of cases
with elevated variant allele expression was not statisti-
cally different from controls (Fisher's exact test, p > 0.8).
Therefore, although our data provide significant evidence
of SCN5A allelic expression imbalance in heterozygous
African-American hearts, there is no evidence for an
association with the risk of SIDS.
Discussion
Inherited arrhythmias are a leading cause of sudden car-
diac death in infants, children, and adolescents [2]. Afri-
can-American infants have a two-fold higher risk of
sudden death as compared with Caucasian infants [5].
One potential explanation of sudden death risk in Afri-
can-Americans comes from work on the common genetic
variant SCN5A-p.Ser1103Tyr. Thirteen percent of Afri-
can-Americans carry at least one copy of the SCN5A-
p.Tyr1103 missense variant, for which in vitro evidence
supports having a potential pathophysiologic role in
increased cardiac arrhythmia risk [7]. Plant and col-
leagues demonstrated an over-representation of homozy-
gous SCN5A-p.Tyr1103 subjects in a cohort of 133
African-American SIDS victims [9]. This study further
demonstrated that SCN5A-p.Tyr1103 channels exhibit
increased persistent sodium current (an arrhythmia sus-
ceptibility mechanism observed in LQTS) particularly
when exposed to intracellular acidosis. A subsequent
study demonstrated a significantly higher prevalence of
heterozygous SCN5A-p.Ser1103Tyr carriers among 71
African-American cases of sudden unexplained infant
deaths as compared with African-American controls [10].
We hypothesized that some African-Americans
heterozygous for SCN5A-p.Ser1103Tyr have allelic
expression imbalance with predominance of the variant
gene copy. In this situation, greater relative expression of
the minor allele (p.Tyr1103) might contribute more to
arrhythmia susceptibility and further increase the risk of
sudden cardiac death. Our data suggest that allelic
expression imbalance occurs with SCN5A but we did not
observe a significant difference in allelic expression ratios
or the proportion of cases with elevated variant expres-
sion. One potential limitation of our study stems from
alternative splicing of SCN5A mRNA. Our assay condi-
tions do not distinguish expression of the two alleles pres-
ent on differentially spliced SCN5A transcripts and
therefore we can not exclude that allelic expression
imbalance involves a specific splice variant.
Many autosomal genes can exhibit multi-fold differ-
ences in allele-specific expression even in healthy tissues
[11,12]. In some settings, such as breast cancer associated
with BRCA1 or BRCA2 mutations, allelic expression
imbalance may underlie increased disease risk [15]. The
most likely explanation for this phenomenon is the pres-
ence of cis-regulatory polymorphisms [16]. A prior study
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was associated with significantly reduced promoter activ-
ity measured in vitro and correlated with variability in PR
interval, QRS duration, and QRS widening during expo-
sure to sodium channel blocking drugs [17]. This particu-
lar variant haplotype was not present in African-
Americans, and the study did not examine allelic varia-
tion in cardiac SCN5A expression. But this work did
establish a precedent for predicting that allelic expression
imbalance in SCN5A may occur and may have potential
clinical consequences.
Conclusions
In conclusion, our study demonstrated that allelic varia-
tion in cardiac SCN5A expression occurs in African-
Americans heterozygous for p.Ser1103Tyr. This finding is
biologically important because it demonstrates that
SCN5A gene expression can exhibit allelic imbalance.
However, this phenomenon alone was not associated
with risk for SIDS in the cohorts we examined. Allelic
expression imbalance in SCN5A could be one mechanism
among a host of genetic, epigenetic, and environmental
phenomena that together modify sudden death risk in
other susceptible hosts.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
SASK designed and performed experiments, analyzed data and wrote the
manuscript. JK assisted with experiments and data analysis. LW contributed to
statistical analysis of data. AL, BL and MJA procured tissue samples. ALG con-
ceived of the study, helped plan experiments, analyzed data and wrote the
manuscript. All authors have read and approved the final manuscript.
Acknowledgements
This work was supported by NIH grants HL083374 (A.L.G.) and HD42569 (M.J.A.) 
and institutional training grant T32-HL007256-30 (S.A.S.K.).
Author Details
1Department of Pediatrics, Vanderbilt University, Nashville, TN, USA, 
2Department of Medicine, Vanderbilt University, Nashville, TN, USA, 
3Department of Biostatistics, Vanderbilt University, Nashville, TN, USA, 
4Tennessee Medical Examiner's Office, Nashville, TN, USA and 5Department of 
Pediatrics, Mayo School of Medicine, Rochester, MN, USA
References
1. Arshad A, Mandava A, Kamath G, Musat D: Sudden cardiac death and the 
role of medical therapy.  Prog Cardiovasc Dis 2008, 50:420-438.
2. Sarkozy A, Brugada P: Sudden cardiac death and inherited arrhythmia 
syndromes.  J Cardiovasc Electrophysiol 2005, 16(Suppl 1):S8-S20.
3. Gillum RF: Sudden cardiac death in Hispanic Americans and African 
Americans.  Am J Public Health 1997, 87:1461-1466.
Received: 26 October 2009 Accepted: 14 May 2010 
Published: 14 May 2010
This article is available from: http://www.biomedcentral.com/1471-2350/11/74© 2010 Killen et a ; lic nsee BioMed Central Ltd. is an Open Access article distributed under th  terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.BMC Medical Genetic  2010, 11:74
Figure 1 Allelic variation in cardiac SCN5A expression in African-American infants. (A) The log2 p.Tyr1103:p.Ser1103 allelic expression ratios for 
all cases and controls are plotted as a function of the count and fitted with Gaussian functions (red line). The goodness of fit for a two component 
model was significantly better than a single mode (p < 0.0001), thus demonstrating a bimodal distribution of allelic expression ratios. (B) Distribution 
of log2 allelic expression ratios for SIDS cases and controls. Red colored symbols represent subjects with log2 allelic expression ratios significantly dif-
ferent from zero using a Bonferroni corrected level of significance (p < 0.002).
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